Martin Emery of GMO examines whether the recent pickup in foreign equity flows to India marks a structural shift or a temporary response to sentiment and market dynamics.
-
Despite a rebound in flows since April, India remains a short in GMO’s Systematic Global Macro Strategy due to stretched valuations and muted investor sentiment.
-
Foreign allocations have historically tracked momentum and risk appetite—both of which remain unfavourable in the current environment.
-
GMO’s models continue to project underperformance relative to other EMs, citing elevated profit margins and modest return expectations.
For a closer look at the disconnect between capital flows and fundamentals, read the full analysis.
To read this article, you need a subscription to Investment Officer. If you don't have a subscription yet, click on 'Subscribe' to see the various subscription options.
